Results 31 to 40 of about 146,046 (188)
ABSTRACT The Clinical and Laboratory Standards Institute M100 document serves as a cornerstone standard for clinical microbiology laboratories in China. Maintaining the scientific rigor of its predecessors, the 36th edition incorporates updated epidemiological cutoff values, pharmacokinetic/pharmacodynamic data, and clinical efficacy evidence to revise
Kanghong Xu, Qi Wang, Hui Wang
wiley +1 more source
Heteroresistance to Amikacin in Carbapenem-Resistant Klebsiella pneumoniae Strains
Heteroresistance can lead to treatment failure and is difficult to detect by the methods currently employed by clinical laboratories. The aim of this study was to investigate the prevalence of the amikacin-heteroresistant Klebsiella pneumoniae strains ...
Feiyang Zhang +7 more
doaj +1 more source
Abstract Objectives Biliary atresia (BA) is a cholangiopathy characterized by obstruction of the intrahepatic and extrahepatic bile ducts. Hepatic portoenterostomy (HPE) is the primary palliative treatment and there is still an urgent need to improve post‐HPE management.
Bianca Ferraz de Almeida Silva +7 more
wiley +1 more source
Raman spectroscopy successfully identified antibiotic‐resistant Gram‐negative strains. Resistant strains of four bacterial species were discriminated from sensitive ones with 99.1% accuracy using PLS regression. The method allows for rapid, label‐free detection of antibiotic resistance.
Fernanda Sant Ana de Siqueira e Oliveira +3 more
wiley +1 more source
Aminoglycosides are essential components in the available armamentarium to treat bacterial infections. The surge and rapid dissemination of resistance genes strongly reduce their efficiency, compromising public health.
Ophélie d’Udekem d’Acoz +11 more
doaj +1 more source
Amikacin and renal Impairment: optimized dosing regimens by pharmacokinetic simulation according to KDIGO Stages. [PDF]
Introduction: Pharmacokinetic simulations enable evaluation of the impact of dosing regimens and administration intervals on the achievement of therapeutic targets for amikacin, particularly in patients with renal impairment.
Fatima Zohra BOUAOUA +23 more
doaj +1 more source
Advancing Therapies for Mycobacterial Diseases: From Small Molecules to Host‐Directed Strategies
ABSTRACT The global burden of multidrug‐resistant tuberculosis (MDR‐TB) and the rising incidence of nontuberculous mycobacterial (NTM) infections highlight the urgent need for innovative therapeutic strategies. Current treatments are prolonged, toxic, and increasingly compromised by resistance and limited diagnostic capacity.
Tânia Silva +23 more
wiley +1 more source
ISOLATION AND CHARACTERIZATION OF CITROBACTER FREUNDII FROM FRESH WATER COMMON CARP (CYPRINUS CARPIO) IN MOSUL CITY [PDF]
Citrobacter freundii is an opportunistic pathogen in animals and humans. The current study aimed to isolate C. freundii from the intestines of common carp (Cyprinus carpio) and test their antibiotic susceptibility.
MOHAMMAD HAMAD +2 more
doaj +1 more source
An oxygen‐responsive living bioreactor was engineered via interspecies protoplast fusion, converting oxygen from an inhibitory stress into a programmable signal for sustained indole‐3‐propionic acid (IPA) production. This genetically encoded bioreactor enables robust aerobic operation and therapeutic efficacy of deoxynivalenol detoxification in vivo ...
Ning Ma +8 more
wiley +1 more source
Urinary tract infections (UTI) are common infections that can be mild to life threatening. However, increased bacterial resistance and poor patient compliance rates have limited the effectiveness of conventional antibiotic therapies.
Zi-Xing Zhong +25 more
doaj +1 more source

